Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 May;92(2):256–262. doi: 10.1111/j.1365-2249.1993.tb03389.x

Increased epithelial expression of HLA-DQ and HLA-DP molecules in salivary glands from patients with Sjögren's syndrome compared with obstructive sialadenitis.

P S Thrane 1, T S Halstensen 1, H R Haanaes 1, P Brandtzaeg 1
PMCID: PMC1554793  PMID: 8485911

Abstract

Salivary gland specimens from 10 patients with primary Sjögren's syndrome (pSS) were examined by two-colour immunofluorescence with various combinations of monoclonal and polyclonal antibody reagents of the following specificities: human leucocyte antigen (HLA) class I and II (DR, DP and DQ), CD3, CD45 (leucocyte common antigen), various cytokeratins, and factor VIII-related antigen. Tissue specimens from 10 normal glands and 10 glands with obstructive sialadenitis (no known autoimmunity) served as controls. Only some intercalated ducts and scattered acini of the normal major glands expressed HLA class II determinants (< 5% of total epithelial area); the relative proportion of positive elements indicated differential expression (DR > DP > DQ). SS glands contained substantial T cell infiltrates and increased numbers of activated (DR+) T cells; adjacent epithelium showed extensive differential expression of HLA class II determinants (DR > DP > DQ). Glands with obstructive sialadenitis showed similarly increased epithelial expression of HLA-DR but with surprisingly small amounts of concomitant HLA-DP and -DQ expression. Epithelial HLA class II expression probably depends on cytokines as an inductive event, which is not unique for SS but particularly prominent in this disorder. Our results suggest that epithelial expression of HLA-DP or -DQ, rather than -DR, might be a prerequisite for the autoimmune process of SS to develop in genetically susceptible individuals.

Full text

PDF
256

Images in this article

259Fig. 2
on p.259

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson T. C., 3rd, Fox R. I., Frisman D. M., Howell F. V. Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies. J Immunol. 1983 Jan;130(1):203–208. [PubMed] [Google Scholar]
  2. Altmann D. M., Sansom D., Marsh S. G. What is the basis for HLA-DQ associations with autoimmune disease? Immunol Today. 1991 Aug;12(8):267–270. doi: 10.1016/0167-5699(91)90124-C. [DOI] [PubMed] [Google Scholar]
  3. Bottazzo G. F., Todd I., Mirakian R., Belfiore A., Pujol-Borrell R. Organ-specific autoimmunity: a 1986 overview. Immunol Rev. 1986 Dec;94:137–169. doi: 10.1111/j.1600-065X.1986.tb01168.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brandtzaeg P. Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique. Immunology. 1974 Jun;26(6):1101–1114. [PMC free article] [PubMed] [Google Scholar]
  5. Brandtzaeg P., Rognum T. O. Evaluation of tissue preparation methods and paired immunofluorescence staining for immunocytochemistry of lymphomas. Histochem J. 1983 Jul;15(7):655–689. doi: 10.1007/BF01002987. [DOI] [PubMed] [Google Scholar]
  6. Cresswell P. Regulation of HLA class I and class II antigen expression. Br Med Bull. 1987 Jan;43(1):66–80. doi: 10.1093/oxfordjournals.bmb.a072177. [DOI] [PubMed] [Google Scholar]
  7. Daar A. S., Fuggle S. V., Fabre J. W., Ting A., Morris P. J. The detailed distribution of MHC Class II antigens in normal human organs. Transplantation. 1984 Sep;38(3):293–298. doi: 10.1097/00007890-198409000-00019. [DOI] [PubMed] [Google Scholar]
  8. Daniels T. E. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum. 1984 Feb;27(2):147–156. doi: 10.1002/art.1780270205. [DOI] [PubMed] [Google Scholar]
  9. Foulis A. K. Class II major histocompatibility complex and organ specific autoimmunity in man. J Pathol. 1986 Sep;150(1):5–11. doi: 10.1002/path.1711500103. [DOI] [PubMed] [Google Scholar]
  10. Fox R. I., Adamson T. C., 3rd, Fong S., Young C., Howell F. V. Characterization of the phenotype and function of lymphocytes infiltrating the salivary gland in patients with primary Sjogren syndrome. Diagn Immunol. 1983;1(3):233–239. [PubMed] [Google Scholar]
  11. Fox R. I., Bumol T., Fantozzi R., Bone R., Schreiber R. Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome. Arthritis Rheum. 1986 Sep;29(9):1105–1111. doi: 10.1002/art.1780290908. [DOI] [PubMed] [Google Scholar]
  12. Fox R. I., Pearson G., Vaughan J. H. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome. J Immunol. 1986 Nov 15;137(10):3162–3168. [PubMed] [Google Scholar]
  13. Garry R. F., Fermin C. D., Hart D. J., Alexander S. S., Donehower L. A., Luo-Zhang H. Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science. 1990 Nov 23;250(4984):1127–1129. doi: 10.1126/science.1701273. [DOI] [PubMed] [Google Scholar]
  14. Hardcastle J. D., Farrands P. A., Balfour T. W., Chamberlain J., Amar S. S., Sheldon M. G. Controlled trial of faecal occult blood testing in the detection of colorectal cancer. Lancet. 1983 Jul 2;2(8340):1–4. doi: 10.1016/s0140-6736(83)90001-6. [DOI] [PubMed] [Google Scholar]
  15. Harley J. B., Reichlin M., Arnett F. C., Alexander E. L., Bias W. B., Provost T. T. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science. 1986 May 30;232(4754):1145–1147. doi: 10.1126/science.3458307. [DOI] [PubMed] [Google Scholar]
  16. Hirokawa K., Kurashima C., Hayashi Y., Sato K., Miyasaka N. Recent advances in immunopathology of autoimmune diseases in salivary glands. Pathol Immunopathol Res. 1986;5(3-5):239–247. doi: 10.1159/000157017. [DOI] [PubMed] [Google Scholar]
  17. Huitfeldt H. S., Brandtzaeg P. Various keratin antibodies produce immunohistochemical staining of human myocardium and myometrium. Histochemistry. 1985;83(5):381–389. doi: 10.1007/BF00509196. [DOI] [PubMed] [Google Scholar]
  18. Isenberg D. A., Rowe D., Tookman A., Hopp A., Griffiths M., Paice E., Stewart J., Beverley P. C. An immunohistological study of secondary Sjögren's syndrome. Ann Rheum Dis. 1984 Jun;43(3):470–476. doi: 10.1136/ard.43.3.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Itescu S., Brancato L. J., Winchester R. A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet. 1989 Aug 26;2(8661):466–468. doi: 10.1016/s0140-6736(89)92085-0. [DOI] [PubMed] [Google Scholar]
  20. Jonsson R., Klareskog L., Bäckman K., Tarkowski A. Expression of HLA-D-locus (DP, DQ, DR)-coded antigens, beta 2-microglobulin, and the interleukin 2 receptor in Sjögren's syndrome. Clin Immunol Immunopathol. 1987 Nov;45(2):235–243. doi: 10.1016/0090-1229(87)90038-9. [DOI] [PubMed] [Google Scholar]
  21. Konttinen Y. T., Bergroth V., Nordström D., Segerberg-Konttinen M., Tolvanen E. Expression of MHC class II antigen, interleukin-2 receptor, transferrin receptor and gp 40/80 glycoprotein during different phases of a normal PHA-driven lymphocyte activation in vitro. Acta Pathol Microbiol Immunol Scand C. 1986 Oct;94(5):181–186. doi: 10.1111/j.1699-0463.1986.tb02109.x. [DOI] [PubMed] [Google Scholar]
  22. Lindahl G., Hedfors E., Klareskog L., Forsum U. Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome. Clin Exp Immunol. 1985 Sep;61(3):475–482. [PMC free article] [PubMed] [Google Scholar]
  23. Londei M., Lamb J. R., Bottazzo G. F., Feldmann M. Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature. 1984 Dec 13;312(5995):639–641. doi: 10.1038/312639a0. [DOI] [PubMed] [Google Scholar]
  24. Matsui Y., Shapiro H. M., Sheehy M. J., Christenson L., Staunton D. E., Eynon E. E., Yunis E. J. Differential expression of T cell differentiation antigens and major histocompatibility antigens on activated T cells during the cell cycle. Eur J Immunol. 1986 Mar;16(3):248–251. doi: 10.1002/eji.1830160307. [DOI] [PubMed] [Google Scholar]
  25. Moutsopoulos H. M., Hooks J. J., Chan C. C., Dalavanga Y. A., Skopouli F. N., Detrick B. HLA-DR expression by labial minor salivary gland tissues in Sjögren's syndrome. Ann Rheum Dis. 1986 Aug;45(8):677–683. doi: 10.1136/ard.45.8.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Möst J., Knapp W., Wick G. Class II antigens in Hashimoto thyroiditis. I. Synthesis and expression of HLA-DR and HLA-DQ by thyroid epithelial cells. Clin Immunol Immunopathol. 1986 Nov;41(2):165–174. doi: 10.1016/0090-1229(86)90100-5. [DOI] [PubMed] [Google Scholar]
  27. Natali P. G., De Martino C., Quaranta V., Nicotra M. R., Frezza F., Pellegrino M. A., Ferrone S. Expression of Ia-like antigens in normal human nonlymphoid tissues. Transplantation. 1981 Jan;31(1):75–78. doi: 10.1097/00007890-198101000-00017. [DOI] [PubMed] [Google Scholar]
  28. Nel A. E., Wooten M. W., Galbraith R. M. Molecular signaling mechanisms in T-lymphocyte activation pathways: a review and future prospects. Clin Immunol Immunopathol. 1987 Aug;44(2):167–186. doi: 10.1016/0090-1229(87)90064-x. [DOI] [PubMed] [Google Scholar]
  29. Nelson J. L., Hansen J. A. Autoimmune diseases and HLA. Crit Rev Immunol. 1990;10(4):307–328. [PubMed] [Google Scholar]
  30. Pesando J. M., Graf L., Hoffman P. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line. J Immunol. 1986 Sep 15;137(6):1932–1936. [PubMed] [Google Scholar]
  31. Pujol-Borrell R., Todd I., Doshi M., Bottazzo G. F., Sutton R., Gray D., Adolf G. R., Feldmann M. HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature. 1987 Mar 19;326(6110):304–306. doi: 10.1038/326304a0. [DOI] [PubMed] [Google Scholar]
  32. Rowe D., Griffiths M., Stewart J., Novick D., Beverley P. C., Isenberg D. A. HLA class I and II, interferon, interleukin 2, and the interleukin 2 receptor expression on labial biopsy specimens from patients with Sjögren's syndrome. Ann Rheum Dis. 1987 Aug;46(8):580–586. doi: 10.1136/ard.46.8.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Saito I., Servenius B., Compton T., Fox R. I. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J Exp Med. 1989 Jun 1;169(6):2191–2198. doi: 10.1084/jem.169.6.2191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Scott H., Sollid L. M., Fausa O., Brandtzaeg P., Thorsby E. Expression of major histocompatibility complex class II subregion products by jejunal epithelium in patients with coeliac disease. Scand J Immunol. 1987 Nov;26(5):563–571. doi: 10.1111/j.1365-3083.1987.tb02290.x. [DOI] [PubMed] [Google Scholar]
  35. Segerberg-Konttinen M., Bergroth V., Jungell P., Malmström M., Nordström D., Sane J., Immonen I., Konttinen Y. T. T lymphocyte activation state in the minor salivary glands of patients with Sjögren's syndrome. Ann Rheum Dis. 1987 Sep;46(9):649–653. doi: 10.1136/ard.46.9.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sollid L. M., Gaudernack G., Markussen G., Kvale D., Brandtzaeg P., Thorsby E. Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line. Scand J Immunol. 1987 Feb;25(2):175–180. doi: 10.1111/j.1365-3083.1987.tb01061.x. [DOI] [PubMed] [Google Scholar]
  37. Zarbo R. J., Regezi J. A., Lloyd R. V., Crissman J. D., Batsakis J. G. HLA-DR antigens in normal, inflammatory, and neoplastic salivary glands. Oral Surg Oral Med Oral Pathol. 1987 Nov;64(5):577–584. doi: 10.1016/0030-4220(87)90064-8. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES